Home/Filings/4/0000950170-24-015862
4//SEC Filing

dEsparbes Eric 4

Accession 0000950170-24-015862

CIK 0001580063other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:05 PM ET

Size

5.0 KB

Accession

0000950170-24-015862

Insider Transaction Report

Form 4
Period: 2024-02-15
dEsparbes Eric
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-02-15+325,000603,662 total
Footnotes (1)
  • [F1]Consists of 325,000 restricted stock units, 25% of which will vest on February 15, 2025, with the remaining shares vesting in equal semi-annual installments through February 15, 2028, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file

Issuer

BIORA THERAPEUTICS, INC.

CIK 0001580063

Entity typeother

Related Parties

1
  • filerCIK 0001622268

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:05 PM ET
Size
5.0 KB